Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| CEO | Kewalramani Reshma | 110.3K | $52.31M | - |
| VP | Sachdev Amit | 68.5K | $32.50M | - |
| COO | Arbuckle Stuart A | 63.4K | $30.07M | - |
| CFO | WAGNER CHARLES F JR | 51.7K | $24.52M | - |
| VP | | 47.3K | $22.42M | -9,532 |
Transactions
50 transactions · page 9
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2022-05-02 | Bhatia Sangeeta N. | Director | Sell | 177 | $261.50 | $46,285.63 | -1.0% | → |
| 2022-04-29 | Liu Joy | SVP, General Counsel | Sell | 120 | $275.41 | $33,048.88 | -0.2% | → |
| 2022-04-25 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | 327 | $269.55 | $88,143.05 | -2.2% | → |
| 2022-04-18 | Lee Yuchun | Director | Sale+OE | 2,000 | $284.23 | $568,466.64 | -16.9% | → |
| 2022-04-14 | Lee Yuchun | Director | Sale+OE | 2,000 | $289.06 | $578,116.60 | -17.0% | → |
| 2022-04-13 | LEIDEN JEFFREY M | Executive Chairman | Sell | 15,789 | $289.04 | $4,563,652.56 | -17.6% | → |
| 2022-04-13 | Lee Yuchun | Director | Sale+OE | 4,000 | $284.27 | $1,137,060.12 | -10.7% | → |
| 2022-04-11 | Lee Yuchun | Director | Sale+OE | 4,000 | $279.43 | $1,117,739.88 | -18.6% | → |
| 2022-04-08 | MCGLYNN MARGARET G | Director | Sale+OE | 5,000 | $280.22 | $1,401,080.00 | -68.5% | → |
| 2022-04-08 | Bhatia Sangeeta N. | Director | Sale+OE | 1,907 | $280.20 | $534,341.40 | -26.9% | → |
| 2022-04-07 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 561 | $276.18 | $154,934.97 | -0.4% | → |
| 2022-04-07 | Lee Yuchun | Director | Sale+OE | 1,273 | $274.00 | $348,799.48 | -10.4% | → |